Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Become EABM
Become Reviewer

Can we Target the Chemokine Network for Cancer Therapeutics?

Volume:6   Issue: 8
Pp: 659-670
Ryan Giles and Robert D. Loberg
DOI: 10.2174/156800906779010245

The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies

Volume:6   Issue: 8
Pp: 671-679
A. Ferrajoli, S. Faderl, F. Ravandi and Z. Estrov
DOI: 10.2174/156800906779010227

Modulation of the Cell Cycle and Induction of Apoptosis in Human Cancer Cells by Synthetic Bile Acids

Volume:6   Issue: 8
Pp: 681-689
Nam Deuk Kim, Eunok Im, Young Hyun Yoo and Yung Hyun Choi
DOI: 10.2174/156800906779010236

EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer

Volume:6   Issue: 8
Pp: 691-710
Igor Astsaturov, Roger B. Cohen and Paul M. Harari
DOI: 10.2174/156800906779010191

Anti-Invasive and Anti-Metastasis Strategies: New Roads, New Tools and New Hopes

Volume:6   Issue: 8
Pp: 729-751
Laurent Dolle, Herman T. Depypere and Marc E. Bracke
DOI: 10.2174/156800906779010263

ERRATUM promotion: free to download

Volume:6   Issue: 8
Pp: 753-753

DOI: 10.2174/156800906779010254